Physician profile
Cynthia Clark
NPI 1679698849
$2,243.25
in general payments reported to CMS, 2019-2025
15 companies · $702 in 2025
The $702 reported for 2025 was more than what 95% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $50.85 · 2022: $485 · 2023: $319 · 2024: $687 · 2025: $702.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,708.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,707.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $799.95 | 2022-2025 | |
| Viiv Healthcare Company | $479.14 | 2023-2025 | Dovato, Apretude, Cabenuva |
| Gilead Sciences, INC. | $340.09 | 2021-2024 | |
| Astellas Pharma US INC | $165.56 | 2024 | Veozah |
| Abbott Laboratories | $138.51 | 2024 | Freestyle Libre 3 |
| Dexcom, INC. | $108.11 | 2024-2025 | Dexcom G6 Transmitter |
| Hologic Sales and Service, LLC | $46.85 | 2025 | Aptima |
| Dynavax Technologies Corporation | $37.69 | 2023-2024 | Heplisav-B |
| Lilly USA, LLC | $23.96 | 2024 | Zepbound |
| Pfizer INC. | $20.85 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.26 | 2025 | |
| Corcept Therapeutics | $17.85 | 2025 | Korlym |
| Indivior INC. | $17.23 | 2023 | Sublocade |
| Merck Sharp & Dohme LLC | $14.74 | 2023 | Vaxneuvance, M-M-R II, Gardasil 9 |
| Novo Nordisk INC | $13.46 | 2023 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cynthia Clark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.